◆ 会议时间：2026年5月14-17日
◆ 会议地点：捷克 布拉格

◆ 会议简介：

2026年第15届国际自身免疫大会(Autoimmunity 2026)将于2026年5月14-17日在捷克布拉格举行，会议由国际自身免疫网络组织主办。国际自体免疫大会是全球最大的以自身免疫为主题宣的多学科学术会议，由世界上最杰出的专家提供课程和讲座，预计有来自世界各地的两千多名风湿病学家、内科医生、免疫学家、肾病学家等相关专业人士与会，大会议题涉及抗磷脂综合征，自身免疫性疾病的机制和病因，癌症和自身免疫，中枢神经系统和自身免疫，血液病和自身免疫，微生物组和自身免疫等等。未经许可禁止复制摘录转载本站任何内容国际医学会议网(lingyuint.com)

Autoimmunity 2026 - 15th International Congress on Autoimmunity

Date: 14-17 May, 2026
Venue: Prague, Czech Republic

The 15th International Congress on Autoimmunity is heading to Prague. Join us in person to learn, grow and network with renowned professionals. We will discuss the newest therapeutic techniques and diagnostic tools as well as the most up-to-date research and novel therapies of autoimmune diseases.

摘要征集-Abstract Submission：

Abstract Submission Open 1 July 2025
Abstract Submission Deadline 4 November 2025
Abstract Submission Notifications Mid- December 2025

点此提交摘要>>>Submit Abstract>>>

* Please note that all efforts are made to send notification by the planned date. Should there be any delays with the selection process, the revised date will be posted here.

Rules for Submission

Please read the submission rules before submitting an abstract.

• Abstracts must be submitted online via the website only. ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
• Presentation Type: Abstracts may be submitted for oral presentation or poster viewing.
  The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
• Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.

Limitations

• The same person may submit up to 5 abstracts regardless of presenting author.
• The same person may serve as the presenting author on up to 3 abstracts.
• Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by the Early Registration Deadline will be scheduled for presentation and included for publication.
• Submission of an abstract acknowledges your acceptance for the abstract to be published in the official congress publications.
• The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
• Previously Presented/Published Policy: Abstracts that have been previously presented at another meeting may be submitted.
• Abstracts must be submitted in English.
  All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university-specific publications office (or other similar facilities), or by a copy editor, prior to submission.
• Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.
• Instructions for the preparation of presentations will be made available on the congress website.

Guidelines for Submission

Before you begin, please prepare the following information:

• ​Presenting author’s contact details:
  – Full first and family name(s)
  – Email address
  – Affiliation details: department, institution / hospital, city, state (if relevant), country
  – Phone number
• Author and co-authors’ details
• Preferred Presentation type: oral presentation or poster viewing.
• Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words.
• Abstract text- limited to 250 words including acknowledgments. Please note: word count is affected when tables are included.
• Abstract topic – select the abstract topic per the list of topics.
• Images - The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixels. You may upload images in JPG, GIF, or PNG format.
• Abstracts should clearly state:
  Background and aims
  Methods
  Results
  Conclusions
• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
• Submissions may not contain patient names, hospital ID numbers, or other identifying information.
• Click on the SUBMIT button at the end of the process in order to save your abstract. You may log in to the system later to make changes to your abstract, up to the submission deadline. After the deadline, changes will not be possible.
• You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
• Please contact us if you have not received confirmation that your abstract has been submitted.
• Please do not submit multiple copies of the same abstract.

Abstract Submitters’ Declaration

During abstract submission you will be asked to confirm that you agree to the following:

• I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.
• Submission of the abstract constitutes the consent of all authors to publication (e.g. Congress website, programs, other promotions, etc.)
• The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the “Content“) to AUTO 2026 and Kenes International (Hereafter: the “Organizers“), nor the publication of any such Content by the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.
• The Abstract Submitter grants the Organizers a copyright license to reproduce, publish, translate, distribute, and display the text of the Content on a royalty-free, perpetual, irrevocable nonexclusive basis.
• I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.
• I understand that the presenting author must be a registered participant.
• The Organizers reserve the right to remove from publication and/or presentation an abstract that does not comply with the above.
• I understand that I must select a specific Theme, Topic, and/or Sub-Topic for my abstract allocation.  Although the Committee will work hard to honor this selection, this cannot be guaranteed.  The Committee reserves the right to change the Theme, Topic, or Sub-Topic under which the abstract was originally submitted.

Dear Colleagues and Friends,

I am delighted to extend a warm invitation to the 15th International Congress on Autoimmunity, taking place 14-17 May 2026 in the picturesque city of Prague, Czech Republic.

Autoimmunity 2026 continues our tradition of bringing together a diverse community of clinicians, researchers, and healthcare professionals dedicated to the study and treatment of autoimmune diseases. Our scientific program will feature plenary sessions, parallel tracks, debates , sevra teaching courses, and oral presentations of selected abstracts, providing a comprehensive platform for sharing knowledge and fostering collaboration.

Each Autoimmunity Congress welcomes over 1,500 experts from more than 70 countries, fostering a vibrant and truly global community of professionals dedicated to autoimmune research and care. The upcoming congress aims to build on this legacy, offering opportunities to engage with the latest research, discuss emerging therapies, and connect with colleagues from around the world.

Prague, with its rich cultural heritage and architectural beauty, offers an inspiring setting for our gathering. The city’s blend of history and modernity provides a unique backdrop for both professional development and personal enrichment.

I look forward to welcoming you to Autoimmunity 2026 and to the opportunity to engage in fruitful discussions that advance our shared commitment to improving patient care in autoimmune diseases.

Sincerely,

Prof. Yehuda Shoenfeld, MD, FRCP, MaACR
Congress President

注册费：Participation Fees (in EUR) apply to payments received prior to the indicated deadlines.

* Trainee (Student/Fellow/Nurse) – status must be certified – An official supportive letter from the institution, signed by the head of the department confirming your status, or a valid status ID card must accompany the registration

** In order to register to the Workshops, it’s mandatory to be registered for the Congress.

*** Learn more about the topics that will be presented during the upcoming Academy of Autoimmunity and save your seat.

*** Learn more about the upcoming pre-congress workshops on Ultrasound and AI Workshop.

REGISTRATION FEES INCLUDE:

• Participation in all Scientific Sessions
• Entrance to the Exhibition and E-Posters area
• Invitation to the Opening Ceremony and Welcome Reception
• Coffee and Lunch during breaks, as indicated in the program
• Certificate of Attendance (sent via email after the congress)
• The opportunity to earn CME credits for your participation in Autoimmunity 2026

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。